{"data":[{"accessionNo":"0002100119-26-001565","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics Inc","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":2846786,"percentOfClass":5.08,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-26-005203","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Alex Silverstein","reportingCik":null,"personType":"HC,IN","sharesOwned":1696751,"percentOfClass":3.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-26-005203","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Sirenia Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1696751,"percentOfClass":3.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902219-26-000243","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":3229882,"percentOfClass":5.9,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902219-26-000243","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":3229882,"percentOfClass":5.9,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902219-26-000243","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":3229882,"percentOfClass":5.9,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902219-26-000243","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":3229882,"percentOfClass":5.5,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001897612-26-000577","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"DIANTHUS THERAPEUTICS INC","ticker":"DNTH","cusip":"252828108","securityClass":"COMMON STOCK","eventDate":"2026-07-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":6632303,"percentOfClass":12.1,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001897612-26-000576","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"DIANTHUS THERAPEUTICS INC","ticker":"DNTH","cusip":"252828108","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":3888456,"percentOfClass":7.1,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0002012383-26-002551","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"DIANTHUS THERAPEUTICS INC","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":3504166,"percentOfClass":6.4,"filedAt":"2026-07-28","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-26-003219","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Alex Silverstein","reportingCik":null,"personType":"HC,IN","sharesOwned":2798122,"percentOfClass":5.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-26-003219","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Sirenia Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2798122,"percentOfClass":5.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902219-26-000166","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":2595783,"percentOfClass":4.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902219-26-000166","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":2595783,"percentOfClass":4.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902219-26-000166","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":2595783,"percentOfClass":4.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001346824-26-000153","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":2611733,"percentOfClass":4.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001346824-26-000153","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":2611733,"percentOfClass":4.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001346824-26-000153","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":2611733,"percentOfClass":4.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001346824-26-000153","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2611733,"percentOfClass":4.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-26-003494","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":643599,"percentOfClass":1.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-26-003494","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":643599,"percentOfClass":1.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-26-003494","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":643599,"percentOfClass":1.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001214659-26-006203","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Ting Jia","reportingCik":null,"personType":"HC,IN","sharesOwned":1946667,"percentOfClass":3.6,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001214659-26-006203","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Octagon Capital Advisors LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1946667,"percentOfClass":3.6,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001214659-26-006203","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Octagon Investments Master Fund LP","reportingCik":null,"personType":"PN,OO","sharesOwned":1655000,"percentOfClass":3,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001214659-26-006203","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Octagon Biotech Opportunities Fund I LP","reportingCik":null,"personType":"PN,OO","sharesOwned":291667,"percentOfClass":0.6,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0002012383-26-001740","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"DIANTHUS THERAPEUTICS INC","ticker":"DNTH","cusip":"252828108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2634004,"percentOfClass":5.1,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902664-26-001155","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2981674,"percentOfClass":6.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902664-26-001155","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":2981674,"percentOfClass":6.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902664-26-001155","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":2981674,"percentOfClass":6.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001346824-26-000039","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2611733,"percentOfClass":6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001346824-26-000039","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":2611733,"percentOfClass":6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001346824-26-000039","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":2611733,"percentOfClass":6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001346824-26-000039","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":2611733,"percentOfClass":6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001104659-25-116119","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001690585","issuerName":"DIANTHUS THERAPEUTICS, INC.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-21","reportingPerson":"Tomas Kiselak","reportingCik":"0001830177","personType":"IN","sharesOwned":2139635,"percentOfClass":4.9,"filedAt":"2025-11-25","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001104659-25-116119","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001690585","issuerName":"DIANTHUS THERAPEUTICS, INC.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-21","reportingPerson":"Fairmount Funds Management LLC","reportingCik":"0001802528","personType":"IA","sharesOwned":2139635,"percentOfClass":4.9,"filedAt":"2025-11-25","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001104659-25-116119","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001690585","issuerName":"DIANTHUS THERAPEUTICS, INC.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-21","reportingPerson":"Fairmount Healthcare Fund II L.P.","reportingCik":"0001769651","personType":"PN","sharesOwned":2139635,"percentOfClass":4.9,"filedAt":"2025-11-25","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001104659-25-116119","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001690585","issuerName":"DIANTHUS THERAPEUTICS, INC.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-21","reportingPerson":"Peter Evan Harwin","reportingCik":"0001663607","personType":"IN","sharesOwned":2139635,"percentOfClass":4.9,"filedAt":"2025-11-25","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-25-007115","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-17","reportingPerson":"Michael Gregory","reportingCik":null,"personType":"IN,HC","sharesOwned":2104184,"percentOfClass":4.9,"filedAt":"2025-11-19","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-25-007115","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-17","reportingPerson":"Avidity Partners Management LP","reportingCik":"0001791827","personType":"IA,PN","sharesOwned":2104184,"percentOfClass":4.9,"filedAt":"2025-11-19","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-25-007115","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-17","reportingPerson":"Avidity Partners Management (GP) LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":2104184,"percentOfClass":4.9,"filedAt":"2025-11-19","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-25-007115","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-17","reportingPerson":"Avidity Capital Partners Fund (GP) LP","reportingCik":null,"personType":"PN","sharesOwned":2104184,"percentOfClass":4.9,"filedAt":"2025-11-19","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-25-007115","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-17","reportingPerson":"Avidity Capital Partners (GP) LLC","reportingCik":null,"personType":"OO","sharesOwned":2104184,"percentOfClass":4.9,"filedAt":"2025-11-19","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000919574-25-007115","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-11-17","reportingPerson":"Avidity Private Master Fund I LP","reportingCik":null,"personType":"PN","sharesOwned":1899593,"percentOfClass":4.4,"filedAt":"2025-11-19","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001231919-25-000486","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":3866733,"percentOfClass":9.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001231919-25-000486","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3866733,"percentOfClass":9.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001231919-25-000486","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":3866733,"percentOfClass":9.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001231919-25-000486","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":3866733,"percentOfClass":9.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001214659-25-016717","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Octagon Capital Advisors LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2416667,"percentOfClass":6.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001214659-25-016717","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Ting Jia","reportingCik":null,"personType":"HC,IN","sharesOwned":2416667,"percentOfClass":6.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001214659-25-016717","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Octagon Investments Master Fund LP","reportingCik":null,"personType":"PN,OO","sharesOwned":2125000,"percentOfClass":5.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001193125-25-283109","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"DIANTHUS THERAPEUTICS, INC.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"BCLS Fund III Investments, LP","reportingCik":null,"personType":"PN","sharesOwned":1315892,"percentOfClass":3.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902664-25-005000","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Ryan Wilder","reportingCik":null,"personType":"HC,IN","sharesOwned":1180000,"percentOfClass":3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902664-25-005000","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Vestal Point Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1180000,"percentOfClass":3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001214659-25-016717","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Octagon Private Opportunities Fund II LP","reportingCik":null,"personType":"PN,OO","sharesOwned":291667,"percentOfClass":0.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001172661-25-004823","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-09-30","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001172661-25-004823","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-09-30","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001172661-25-004823","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 Par Value","eventDate":"2025-09-30","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902219-25-000435","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":2577662,"percentOfClass":6.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902219-25-000435","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":2577662,"percentOfClass":6.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902219-25-000435","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":2577662,"percentOfClass":6.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000902219-25-000435","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc.","ticker":"DNTH","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":2577662,"percentOfClass":6.3,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000315066-25-002720","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001690585","issuerName":"DIANTHUS THERAPEUTICS INC","ticker":"DNTH","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":5970638,"percentOfClass":15,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0000315066-25-002720","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001690585","issuerName":"DIANTHUS THERAPEUTICS INC","ticker":"DNTH","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":5970638,"percentOfClass":15,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001104659-25-090015","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-11","reportingPerson":"Tomas Kiselak","reportingCik":"0001830177","personType":"IN","sharesOwned":4052052,"percentOfClass":9.9,"filedAt":"2025-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001104659-25-090015","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-11","reportingPerson":"Fairmount Funds Management LLC","reportingCik":"0001802528","personType":"IA","sharesOwned":4052052,"percentOfClass":9.9,"filedAt":"2025-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001104659-25-090015","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-11","reportingPerson":"Fairmount Healthcare Fund II L.P.","reportingCik":"0001769651","personType":"PN","sharesOwned":4052052,"percentOfClass":9.9,"filedAt":"2025-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001104659-25-090015","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-11","reportingPerson":"Peter Evan Harwin","reportingCik":"0001663607","personType":"IN","sharesOwned":4052052,"percentOfClass":9.9,"filedAt":"2025-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"},{"accessionNo":"0001104659-25-090015","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001690585","issuerName":"Dianthus Therapeutics, Inc. /DE/","ticker":"DNTH","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-11","reportingPerson":"Fairmount SPV III, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/dnth"}],"updatedAt":"2026-11-03T21:32:13.639Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/dnth","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}